GLP1R Treatment Linked to low Suicidal Ideation in Adolescents with Obesity: JAMA Dr Riya Dave8 Nov 2024 6:00 AM ISTResearchers found that adolescents treated with a glucagon-like peptide 1 receptor agonist (GLP1R) for obesity experienced lower risk for suicide...
Semaglutide treatment may substantially reduce obesity prevalence and CVD events Niveditha Subramani23 Aug 2023 10:00 AM ISTCardiovascular diseases (CVD) and obesity are linked over a long period of time, with growing medical sciences newer management methods are brought to...
SGLT2 inhibitors and GLP1-receptor agonists reduce CHD risk in diabetes patients: Study Medha Baranwal22 March 2021 3:15 AM ISTItaly: Both SGLT2 inhibitors and GLP1-receptor agonists reduce the 10-year risk for cardiovascular disease in type 2 diabetes (T2D) patients without...
